In what may be a first, a researcher in Turkey has withdrawn a paper because the patients whose cases she described wthdrew their consent after it was published.
Here’s the notice, from Allergy, Asthma, & Clinical Immunology, of a paper titled “Severe contact dermatitis due to camomile: a common complementary remedy with potential sensitization risks:” Continue reading Camomile allergy case report retracted after patients withdraw consent post-publication
The corresponding author of a paper on whether “a sense of shame heightens the desire for money” has retracted it, he claims, after being unable to repeat his analysis to try to fix an issue in the study.
Here’s the notice for “Shame for money: Shame enhances the incentive value of economic resources,” which appeared in Judgment and Decision Making: Continue reading A real shame: Psychology paper retracted when data behind problematic findings disappear
We’ve come across some odd examples of plagiarism in this job, from the fellow who tried to build a CV on the back of another researcher’s work, to the education researcher who, from what we can tell, preferred lifting the work of others to writing her own papers. Here’s another odd one for the pile.
A group of Iranian scholars has lost a paper in Brain Injury because they lifted it wholesale from a previously published article. What’s harder to get one’s mind around, however, is that the two papers were looking at culturally-specific aspects of brain injury. Except that one wasn’t.
The retracted paper, “Frontal acquired brain injury, substance abuse and their common psychological symptoms in the Iranian population,” appeared in 2011. Here’s the abstract, which is still available on the journal’s website (we’ll note that although the abstract is free for all, the retraction notice was behind a pay wall — an error, according to the publisher, which they remedied when we contacted them): Continue reading The brains in Spain fall mainly on…Iran?
A group of European researchers is retracting their 2012 paper in Thorax on the link between cystic fibrosis and the common cold after discovering that the first author, a promising young microbiologist in Switzerland, had made up her data.
The article, titled “Impaired type I and type III interferon induction and rhinovirus control in human cystic fibrosis airway epithelial cells,” purported to describe:
a novel mechanism to explain the increased susceptibility of patients with CF to rhinovirus infections. A profound impairment of the antiviral early innate response in CF airway epithelial cells was identified, suggesting a potential use of IFNs in the treatment of rhinovirus-induced CF exacerbations.
The lead author was Marjolaine Vareille, who at the time was at the University of Bern. Vareille won a L’Oréal France grant in 2007 from the Fondation L’Oréal – Unesco-French Academy of Sciences. The paper has been cited eight times, according to Thomson Scientific’s Web of Knowledge.
But according to the retraction notice: Continue reading Thorax retracts cystic fibrosis paper with bogus data
Hisashi Moriguchi, who retracted two papers last year because he and his colleagues could not “guarantee the accuracy of the results and conclusions,” has now had another paper withdrawn — at least temporarily.
A notice on the paper, “Autologous human cardiac stem cells transplantation for the treatment of ischaemic cardiomyopathy: first study of human-induced pluripotent stem (iPS) cell-derived cardiomyocytes transplantation,” which appeared in BMJ Case Reports, now reads: Continue reading Dubious stem cell researcher Moriguchi notches temporary withdrawal, notice of redundant publication
An Australian university has put a hold on trials of an experimental drug for skin cancer whose main developer has been dogged by charges of research misconduct for several years.
The Australian Broadcasting Corporation is reporting that the University of New South Wales has suspended trials of the drug, DZ13, while it investigates the work of Levon Khachigian, who is leading the studies.
According to the news organization, Khachigian and his group were cleared by the school in two prior inquiries. However, additional accusations of misconduct — specifically involving image manipulation and misuse — prompted a third investigation.
We’ve found four retractions of Khachigian’s studies, from the Journal of Biological Chemistry and Biochemical and Biophysical Research Communications, between 2009 and 2010 (before the launch of Retraction Watch).
The Office of Research Integrity (ORI) has sanctioned an assistant professor of dermatology at Case Western Reserve University in Cleveland for plagiarizing from a grant application she was reviewing — which feels like a scientific version of insider trading — and a number of published papers.
According to the ORI’s findings, Pratima Karnik Continue reading Case Western dermatology department hit with second ORI sanction within 6 months
Five months after the Office of Research Integrity announced they had found evidence of misconduct by Adam Savine, a former Washington University graduate student in neuroscience, another journal has published a retraction of his work.
Here’s the retraction notice in the Journal of Experimental Psychology: General for “A characterization of individual differences in prospective memory monitoring using the Complex Ongoing Serial Task”:
Continue reading Third retraction appears for former Wash U neuroscience grad student who committed misconduct
A group of animal health researchers from the Chinese Academy of Agricultural Sciences have lost their 2009 paper in the Journal of Microbiology and Biotechnology because they’d published the data in at least four other articles.
The paper, “Two Novel Duck Antibacterial Peptides, Avian β-Defensins 9 and 10, with Antimicrobial Activity,” reported that: Continue reading Birds of a feather: Authors who play games with fowl data earn multiple retractions
It was the last study ever published from prominent scientist Gerd Maul’s lab. And now it’s been retracted.
Maul was a highly cited cell biologist, with 30 papers cited at least 100 times, according to Thomson Scientific’s Web of Knowledge. He was also a well-known sculptor. When he died in 2010, he had a paper under submission at Cancer Research, which was published late that year.
This year, however, his co-authors found problems with the study. And as the notice — one of the most detailed we’ve ever seen — explains: Continue reading A sad postscript: Paper by deceased researcher retracted